I
Inhibikase Therapeutics, Inc. (IKT)
NCM – Real vaqt narxi. Valyuta: USD
1.92
-0.11 (-5.42%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NCM – Real vaqt narxi. Valyuta: USD
1.92
-0.11 (-5.42%)
Yopilishda: May 12, 2026, 4:00 PM EDT
This stock has a consensus price target of $5.50 based on the ratings of 7 analysts. The high is $8.00 and the low is $3.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 3 | $ 5.5 | $ 8 |
| O’zgarish | 47.78% | 170.94% | 294.09% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-03-04 | 108.33% | Ladenburg Thalmann | $4 | Initiates Coverage On | Buy |
| 2026-01-21 | 212.5% | B of A Securities | $6 | Initiates Coverage On | Buy |
| 2025-12-26 | 316.67% | HC Wainwright & Co. | $8 | Assumes | Buy |
| 2025-12-17 | 56.25% | Freedom Broker | $3 | Initiates Coverage On | Buy |
| 2025-12-11 | 108.33% | Cantor Fitzgerald | $4 | Initiates Coverage On | Overweight |